CA1195324A - Morphinane derivatives - Google Patents

Morphinane derivatives

Info

Publication number
CA1195324A
CA1195324A CA000415102A CA415102A CA1195324A CA 1195324 A CA1195324 A CA 1195324A CA 000415102 A CA000415102 A CA 000415102A CA 415102 A CA415102 A CA 415102A CA 1195324 A CA1195324 A CA 1195324A
Authority
CA
Canada
Prior art keywords
lower alkyl
compound
alkyl
aryl
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000415102A
Other languages
English (en)
French (fr)
Inventor
Ernest Mohacsi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1195324A publication Critical patent/CA1195324A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CA000415102A 1981-11-09 1982-11-08 Morphinane derivatives Expired CA1195324A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US319,482 1981-11-09
US06/319,482 US4374139A (en) 1981-11-09 1981-11-09 Levorotatory N-substituted acylmorphinans useful as analgesic agents

Publications (1)

Publication Number Publication Date
CA1195324A true CA1195324A (en) 1985-10-15

Family

ID=23242421

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000415102A Expired CA1195324A (en) 1981-11-09 1982-11-08 Morphinane derivatives

Country Status (18)

Country Link
US (1) US4374139A (OSRAM)
EP (1) EP0079556A3 (OSRAM)
JP (1) JPS5888364A (OSRAM)
KR (1) KR840002357A (OSRAM)
AU (1) AU9027682A (OSRAM)
CA (1) CA1195324A (OSRAM)
DK (1) DK491582A (OSRAM)
ES (2) ES517222A0 (OSRAM)
FI (1) FI823824L (OSRAM)
GR (1) GR78317B (OSRAM)
HU (1) HU187425B (OSRAM)
IL (1) IL67180A0 (OSRAM)
MC (1) MC1490A1 (OSRAM)
NO (1) NO823707L (OSRAM)
NZ (1) NZ202404A (OSRAM)
PH (1) PH18458A (OSRAM)
PT (1) PT75815B (OSRAM)
ZA (1) ZA827905B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423221A (en) * 1982-06-10 1983-12-27 Sisa Pharmaceutical Laboratories, Inc. 7-Carboethoxy-morphinan-6-one compounds
US4454141A (en) * 1982-09-23 1984-06-12 Sisa Pharmaceutical Laboratories, Inc. Trans-B/C-7-(1-hydroxypentyl)-3-methoxy-17 methyl-6,7-didehydromorphinans, and methods of relieving pain with them
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
DE4304450A1 (de) * 1993-02-13 1994-08-18 Boehringer Mannheim Gmbh System zur Zubereitung von Flüssigkeiten
WO2002036573A2 (en) * 2000-10-31 2002-05-10 Rensselaer Polytechnic Institute 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
PT2506712T (pt) 2009-12-04 2019-05-31 Alkermes Pharma Ireland Ltd Derivados de morfinano para o tratamento da overdose por fármaco
ES2582306T3 (es) 2010-03-22 2016-09-12 Rensselaer Polytechnic Institute Derivados de morfinano que contienen un grupo carboxamida como ligandos de receptores opioides
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
HUE034326T2 (en) 2011-06-29 2018-02-28 Alkermes Inc Peripherally acting opioid compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
JP2016519161A (ja) 2013-05-24 2016-06-30 アルカームス ファーマ アイルランド リミテッド モルファン及びモルフィナン類似物及び使用の方法
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
WO2018125716A1 (en) * 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723437A (en) * 1970-09-15 1973-03-27 American Home Prod 4,10-(methaniminomethano phenanthrene derivatives
ZA73988B (en) * 1972-03-10 1973-10-31 Hoffmann La Roche Morphinan derivatives
US3914233A (en) * 1972-10-20 1975-10-21 Hoffmann La Roche 4-Hydroxy-N-substituted morphinan derivatives

Also Published As

Publication number Publication date
KR840002357A (ko) 1984-06-25
ES8506635A1 (es) 1985-08-01
AU9027682A (en) 1983-05-19
IL67180A0 (en) 1983-03-31
ES8500948A1 (es) 1984-12-01
FI823824A0 (fi) 1982-11-08
EP0079556A2 (de) 1983-05-25
FI823824A7 (fi) 1983-05-10
MC1490A1 (fr) 1983-09-12
NZ202404A (en) 1985-11-08
PT75815A (en) 1982-12-01
GR78317B (OSRAM) 1984-09-26
PH18458A (en) 1985-07-18
US4374139A (en) 1983-02-15
HU187425B (en) 1986-01-28
ZA827905B (en) 1983-08-31
EP0079556A3 (de) 1983-08-24
DK491582A (da) 1983-05-10
NO823707L (no) 1983-05-10
PT75815B (en) 1986-01-21
JPS5888364A (ja) 1983-05-26
ES529349A0 (es) 1985-08-01
ES517222A0 (es) 1984-12-01
FI823824L (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
CA1195324A (en) Morphinane derivatives
US4272541A (en) 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
EP0445974A2 (en) Spirocyclic antipsychotic agents
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤
JPS6350354B2 (OSRAM)
US3644366A (en) 1-amino-3 4-dihydroisoquinolines
US3991194A (en) Heterocyclic esters of benzopyranopyridines
US4241065A (en) Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both
US4473573A (en) N-(2-methoxyethyl)-noroxymorphone and pharmaceutical compositions for relieving pain containing same
CA1100136A (en) 4a-aryl octahydro-1h-2-pyrindines
KR20030053530A (ko) 인돌 유도체 및 그 의약용도
EP0077536B1 (en) 2'-substituted-spiro(benzofuran-2(3h),1'-cycloalkanes), a process for preparing same, pharmaceutical compositions containing such compounds and their use as medicaments
US4194044A (en) Process for preparing 3-phenoxy morphinans
US4533662A (en) 2-Acylaminomethyl-1,4-benzodiazepine compounds and analgesic use
HK24194A (en) Pyrrolo[1,2-a][4,1]benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use
US3753992A (en) Process and intermediates for quinine,quinidine and derivatives thereof
US4247697A (en) 3-Phenoxy morphinans and their derivatives
Koniuszy et al. Erythrina Alkaloids. XVI. Studies on the Constitution of Erysodine, Erysovine and Erysopine
EP0491549B1 (en) Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
US4059586A (en) 5-Alkoxy-2-alkyl-1,2,3,4-tetrahydroisoquinolene-8-carboxaldehyde and derivatives
EP0463691A2 (en) Tricyclic sigma ligands
US3583997A (en) Benzothiopyrano(2,3-c)pyridines
US3047571A (en) Derivatives of oxopiperidinyl phenthiazines
US3950346A (en) Novel process for producing 2-ketoethylbenzomorphan derivatives and salts thereof
EP0009227B1 (en) Fluorination process and fluoro analogs of hydrocodone and oxycodone

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry